EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management

Abu Saadat iD, Francesco Cecere, Federica Rossetti, Laura Pignata, Emilia D'Angelo, Carlo Giaccari, Gaetano Verde, Paola Quarello iD, Franca Fagioli, Josep Roma, Manel Esteller, Enrique de Álava und 3 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Abu Saadat und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania "Luigi Vanvitelli", Caserta, I…. Hauptthemen laut MEDLINE: Wilms Tumor, DNA Methylation, Epigenesis, Genetic, Kidney Neoplasms. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Università e della Ricerca, Accordo per la Coesione della Regione Campania (Project MARADONA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wilms Tumour (WT), the most common kidney cancer in children, presents features of altered kidney development and frequently exhibits molecular alterations at the 11p15.5 imprinted locus, affecting the IGF2 and H19 genes, which contribute to tumour growth and predisposition. The epigenetic landscape beyond 11p15.5 suggests diagnostic and prognostic potential, but its link to transcriptomic changes is largely unexplored. We integrated methylomic and transcriptomic datasets of 27 primary tumours and matched non‐neoplastic kidneys. DNA methylation profiling identified around 9000 differentially methylated CpG sites distinguishing neoplastic from non‐neoplastic tissue and other paediatric cancers, thus representing a novel WT‐specific epigenetic signature. We found that cases with Imprinting Centre 1 (IC1) gain of methylation exhibited the most extensive epigenetic alterations; cases with 11p15.5 loss of heterozygosity showed intermediate changes, whereas regressive tumours with largely normal 11p15.5 status were less affected. Three methylation clusters corresponding to transcriptomic subtypes were identified, characterised by distinct tumour microenvironment and chemosensitivity predictions: a regressive‐enriched, immune‐infiltrated group predicted to respond to paclitaxel, a proliferative group sensitive to doxorubicin, and a stromal‐like intermediate group. Combined analysis of methylation and expression data revealed more than 900 genes under epigenetic control, which contributed to defining the WT subtypes. Analysis of the IGF2 / H19 locus uncovered multiple regulatory mechanisms underlying IGF2 activation, including imprinting defects at IC1, methylation changes at DMR0, differential promoter usage and transcriptional modulation by PLAG1 and BAHD1. These findings define the epigenetic alterations underlying WT heterogeneity and support improved molecular stratification and therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wilms TumorDNA MethylationEpigenesis, GeneticKidney NeoplasmsTranscriptomeHumansGene Expression Regulation, NeoplasticGene Expression ProfilingInsulin-Like Growth Factor IIGenomic ImprintingFemaleCpG Islands

Stichwörter der Autor:innen

IGF2DNA methylation profileWilms tumourepigenetic signaturetranscriptomic profile

Substanzen

Insulin-Like Growth Factor IIIGF2 protein, human

Autor:innen und Institutionen

  • Department of Environmental Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania "Luigi Vanvitelli", Caserta, Italy.
  • Institute of Genetics and Biophysics (IGB) "Adriano Buzzati-Traverso", Consiglio Nazionale delle Ricerche (CNR), Naples, Italy.
  • UOS Laboratori di Ricerca e Biobanca, UOC Ricerca Clinica e Traslazionale, AORN Santobono-Pausilipon, Naples, Italy.
  • Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Pediatric Onco-Haematology Division, Regina Margherita Children's Hospital, Turin, Italy.
  • Department of Public Health and Pediatrics, University of Turin, Turin, Italy.

ORCID-Profile: Abu Saadat, Paola Quarello, Andrea Riccio, Angela Sparago

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Ministero dell'Università e della Ricerca
  • Accordo per la Coesione della Regione Campania (Project MARADONA)
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Saadat, A., Cecere, F., Rossetti, F., Pignata, L., D'Angelo, E., Giaccari, C., Verde, G., Quarello, P., Fagioli, F., Roma, J., Esteller, M., de Álava, E., Cerrato, F., Riccio, A., & Sparago, A. (2026). DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management. International Journal of Cancer. https://doi.org/10.1002/ijc.70680

Vancouver

Saadat A, Cecere F, Rossetti F, Pignata L, D'Angelo E, Giaccari C, et al. DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management. International Journal of Cancer. 2026. doi:10.1002/ijc.70680

BibTeX
@article{Saadat2026,
  author = {Saadat, Abu and Cecere, Francesco and Rossetti, Federica and Pignata, Laura and D'Angelo, Emilia and Giaccari, Carlo and Verde, Gaetano and Quarello, Paola and Fagioli, Franca and Roma, Josep and Esteller, Manel and de Álava, Enrique and Cerrato, Flavia and Riccio, Andrea and Sparago, Angela},
  title = {DNA Methylation and Transcriptomic Profiles of Wilms Tumour Reveal New Deregulated Genes and Epigenetic Processes Relevant for Tumour Stratification and Management},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70680}
}
Kostenlos starten →